Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard's lead asset AT-108 into Phase 1 clinical development -- AT-108 is a transformative immunotherapy that ...
Nantes, France, April 15, 2026 - 7:30am CEST - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage ...
Treatment represents a new approach that could potentially restore brain cells lost due to Parkinson’s disease ...
GLP-1 generics enter the world’s diabetes capital and are added to bridal packages to cut ‘food noise’; can they fix India's ...
Republic Act (RA) 12316—was signed on March 25, 2026 by President Ferdinand Marcos, Jr. This law created a conditional, ...
Researchers at the Université de Genève have built a DNA-based drug delivery system that reads pairs of protein markers on a ...
If you’ve looked at a repair estimate lately and thought the numbers seemed strangely slippery, you’re not imagining things. Modern vehicles are more complicated than they used to be, and even fairly ...
According to a team of researchers at Baylor College of Medicine, Tongji University and collaborating institutions, weaning or switching from milk to solid food in early life doesn't just change what ...
BACKGROUND: Preeclampsia affects approximately 1 in 10 pregnancies, leading to severe complications and long-term health ...
John is a writer at Pocket-lint. He is passionate about all things technology, and is always keeping up with the latest smartphone and PC releases. John has previously written at MobileSyrup. When ...